SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Ramle who wrote (906)6/18/1998 10:34:00 PM
From: Ed Ajootian  Read Replies (2) of 10280
 
Sepracor Inc. Rated New 'Attractive' at Bear Stearns

Princeton, New Jersey, June 17 (Bloomberg Data) -- Sepracor Inc. (SEPR US) was rated ''attractive'' in new coverage by analyst David W. Maris at Bear, Stearns & Co. The 12-month target price is $48.00 per share.

09:44:26 06/17/1998

*******************************************************************************

Maybe today's little pop was a delayed reaction to the above.

Can't believe how wimpy these analysts are. Is this guy judging a beauty contest is he a stock analyst <g>?

And a lousy $48 target --- a lot would have to go _wrong for this thing to only be at $48 this time next year. By then, we will have had at least a couple of quarters of levalbuterol under our belt and it will be in the hyper-growth stage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext